Apc Implantabel Pacing Lead, Model 3264
510(k) K810399
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK810399 | Date15 May 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The APC Implantable Pacing Lead Model 3264 is a Permanent Pacemaker Electrode, a flexible, insulated device designed to transmit electrical impulses from an implanted pacemaker to the heart muscle. It facilitates cardiac pacing by delivering timed electrical stimulation to regulate heart rhythm, ensuring proper cardiac function in patients with bradycardia or conduction disorders.
This lead is inserted transvenously and positioned within the heart, typically as part of a cardiac pacing system. Supplied sterile for single-use, it is regulated under 21 CFR 870.3680 and classified as a Class III device. Authorized via FDA 510(k) clearance (K810399) with a Substantially Equivalent decision, it adheres to cardiovascular medical specialty standards and is intended for use in clinical settings requiring precise cardiac rhythm management.
Other devices from American Pacemaker Corp.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the APC Implantable Pacing Lead, Model 3264, and how does it function in the body?
The APC Implantable Pacing Lead, Model 3264, is designed to transmit electrical impulses from an implanted pacemaker to the heart muscle, helping regulate heart rhythm. It is inserted transvenously and positioned within the heart to deliver timed electrical stimulation, ensuring proper cardiac function in patients with bradycardia (slow heart rate) or conduction disorders. This lead is part of a cardiac pacing system and facilitates precise rhythm management.
Is the APC Implantable Pacing Lead, Model 3264, intended for single-use or can it be reused?
The APC Implantable Pacing Lead, Model 3264, is supplied sterile and intended for single-use only. This ensures patient safety and sterility during implantation, as reusing medical devices like this can introduce risks of infection or device malfunction.
What regulatory pathway was followed for the FDA clearance of this device, and what classification does it fall under?
The APC Implantable Pacing Lead, Model 3264, received FDA clearance through a 510(k) submission with a Substantially Equivalent (SESE) decision, meaning it was deemed comparable to a legally marketed predicate device. It is classified as a Class III device under 21 CFR 870.3680, reflecting its role in life-sustaining or life-supporting functions, and it adheres to cardiovascular medical specialty standards.
How is the device supplied, and what should clinicians consider when handling or storing it?
The APC Implantable Pacing Lead, Model 3264, is supplied sterile and packaged for single-use. Clinicians should ensure the packaging remains unopened and intact until immediate use to maintain sterility. Storage should follow manufacturer guidelines to preserve the device’s integrity, typically in a clean, dry environment away from direct sunlight or extreme temperatures.
What advisory committee reviewed this device during its regulatory submission, and what does that indicate about its intended use?
The device was reviewed by the Cardiovascular (CV) Advisory Committee, which evaluates cardiovascular medical devices. This indicates the lead’s intended use is within the cardiovascular specialty, specifically for precise cardiac rhythm management in clinical settings requiring reliable pacing solutions.